GSK files for US approval of new diabetes drug

GSK files for US approval of new diabetes drug
LONDON (Reuters) – GlaxoSmithKline said on Monday it had filed for U.S. approval of its new once-weekly diabetes drug albiglutide and would make a similar submission shortly in Europe as it vies for a share of a crowded market. Albiglutide belongs to …

Full News here – Read more on Reuters

Leave a Reply